| Axon ID |
Name |
Description |
From price |
|
1368
|
PD184352
|
MEK 1 inhibitor |
€80.00 |
|
1386
|
CHIR99021
|
GSK-3 inhibitor |
€60.00 |
|
1667
|
SU 5402
|
Fibroblast growth factor receptor (FGFR) inhibitor |
€60.00 |
|
2128
|
Stem Cell 2i inhibitor Set
|
Set of MEK inhibitor PD0325901 (Axon 1408) and GSK-3 inhibitor CHIR99021 (Axon 1386) |
€90.00 |
|
2130
|
Stem Cell Alternative 2i inhibitor Set
|
Set of SRC inhibitor CGP77675 (Axon 2097) and GSK-3 inhibitor CHIR99021 (Axon 1386) |
€110.00 |
|
5009
|
Stem Cell 4i inhibitor Set
|
Set of Thiazovivin, SB 431542, PD0325901, and CHIR99021 (inhibitors of ROCK, TGF-β, MEK, and GSK-3 resp.) |
€170.00 |
|
2930
|
Alofanib
|
Allosteric inhibitor of FGFR2 |
€90.00 |
|
2953
|
Roblitinib
|
First-in-class, highly selective and potent FGFR4 inhibitor |
€125.00 |
|
3153
|
BRD5648
|
Negative control compound of BRD0705 as a GSK3α inhibitor |
€210.00 |
|
3154
|
rac-BRD0705
|
GSK3α inhibitor |
€140.00 |
|
2931
|
BRD0705
|
First-in-class, paralog selective GSK3α inhibitor |
€210.00 |
|
3346
|
BIX02188
|
Potent MEK5 inhibitor |
€110.00 |
|
3579
|
Tideglusib
|
GSK-3 inhibitor |
€60.00 |
|
3624
|
Toceranib phosphate
|
Multi-targeted receptor tyrosine kinase inhibitor |
€60.00 |
|
3697
|
Binimetinib
|
Potent, selective, non-ATP-competitive and orally available allosteric inhibitor of MEK1/2 |
€60.00 |
|
3874
|
RDEA119
|
Potent and highly selective small molecule allosteric MEK inhibitor |
Inquire |
|
3973
|
XL-228
|
Multitargeted protein kinase inhibitor (IGF1R, Aurora,FGFR, ABL,ALK and SRC) |
Inquire |
|
3936
|
Bisindolylmaleimide I
|
Potent and selective PKC inhibitor |
€120.00 |
|
4148
|
GDC-0973
|
Orally bioavailable, potent and selective small-molecule inhibitor of mitogen-activated protein kinase 1 |
Recently added
|
Inquire |